Subscribe for free to our flagship newsletter, CDR: This Week in Retail, for news and insights from the voice of retail pharmacy.

Skip to content

Lupin launches generic tetrabenazine tablets

Pharma major Lupin announced the launch of tetrabenazine tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Tetrabenazine Tablets, 12.

MUMBAI and BALTIMORE, Md. — Pharma major Lupin announced the launch of tetrabenazine tablets, 12.5 mg and 25 mg having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Tetrabenazine Tablets, 12.5 mg and 25 mg are the generic equivalent of Valeant Pharmaceuticals North America, LLC’s Xenazine tablets. It is indicated for the treatment of chorea associated with Huntington’s disease.

Latest

RFK Jr. under fire at senate hearing amid CDC turmoil

RFK Jr. under fire at senate hearing amid CDC turmoil

Kennedy appeared yesterday before the Senate finance committee to testify on his Make America Healthy Again agenda after a tumultuous few weeks that ended with more than 1,000 current and former health agency employees accusing him of “putting the health of all Americans at risk”.